INSULIN RESISTANCE AND GEOGRAPHICAL ORIGIN ARE MAJOR PREDICTORS OF LIVER FIBROSIS AND RESPONSE TO PEGYLATED INTERFERON AND RIBAVIRIN IN GENOTYPE 4 CHRONIC HEPATITIS C PATIENTS

被引：2
作者：
Moucari, R. [1 ]
Ripault, M. -P. [1 ]
Martinot-Peignoux, M. [1 ]
Castelnau, C. [1 ]
Voitot, H. [1 ]
El Ray, A. [1 ]
Asselah, T. [1 ]
Boyer, N. [1 ]
Vidaud, M. [1 ]
Bedossa, P. [1 ]
Valla, D. [1 ]
Marcellin, P. [1 ]
机构：
[1] Hop Beaujon, Clichy, France
来源：
JOURNAL OF HEPATOLOGY | 2009年 / 50卷
关键词：
D O I：
10.1016/S0168-8278(09)60637-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
635
引用
收藏
页码：S233 / S234
页数：2
相关论文
共 50 条
[41]   Muscle adiposity influences viral response to pegylated interferon plus ribavirin treatment in patients with genotype 1 chronic hepatitis C [J].
Okada, Michiaki ;
Mizuta, Toshihiko ;
Kitajima, Yoichiro ;
Kawaguchi, Yasunori ;
Iwane, Shinji ;
Ide, Yasushi ;
Eguchi, Yuichiro ;
Anzai, Keizo ;
Ozaki, Iwata .
HEPATOLOGY, 2013, 58 :1152A-1152A
[42]   Association of Serum Cytokine Levels With Treatment Response to Pegylated Interferon and Ribavirin Therapy in Genotype 1 Chronic Hepatitis C Patients [J].
Yoneda, Suguru ;
Umemura, Takeji ;
Katsuyama, Yoshihiko ;
Kamijo, Atsushi ;
Joshita, Satoru ;
Komatsu, Michiharu ;
Ichijo, Tetsuya ;
Matsumoto, Akihiro ;
Yoshizawa, Kaname ;
Ota, Masao ;
Tanaka, Eiji .
JOURNAL OF INFECTIOUS DISEASES, 2011, 203 (08) :1087-1095
[43]   RESPONSE FACTORS TO PEGYLATED INTERFERON-ALFA/RIBAVIRIN TREATMENT IN CHRONIC HEPATITIS C PATIENTS GENOTYPE 1B [J].
Jovanovic-Cupic, Snezana ;
Glisic, S. ;
Stanojevic, M. ;
Vasiljevic, N. ;
Bojic-Milinovic, T. ;
Bozovic, A. ;
Dimitrijevic, B. .
ARCHIVES OF BIOLOGICAL SCIENCES, 2014, 66 (01) :193-201
[44]   Prediction of Sustained Virological Response to Combination Therapy with Pegylated Interferon Alfa and Ribavirin in Patients with Genotype 3 Chronic Hepatitis C [J].
Tohra, S. K. ;
Taneja, S. ;
Ghosh, S. ;
Sharma, B. K. ;
Duseja, A. ;
Dhiman, R. K. ;
Das, A. ;
Chawla, Y. K. .
DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (08) :2449-2455
[45]   Short duration treatment in genotype 1 chronic hepatitis C patients with rapid virologic response to pegylated interferon plus ribavirin [J].
Bonardi, Renato ;
Tabone, Marco ;
Manca, Aldo ;
Pellicano, Rinaldo ;
Ciancio, Alessia ;
Rizzetto, Mario .
BIOMEDICINE & PHARMACOTHERAPY, 2011, 65 (04) :303-306
[46]   Impact of pegylated interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C. [J].
Poynard, T ;
McHutchison, J ;
Manns, M ;
Trepo, C ;
Lindsay, K ;
Goodman, Z ;
Ling, MS ;
Albrecht, JK .
HEPATOLOGY, 2001, 34 (04) :244A-244A
[47]   HEPATITIS C VIRUS CORE GENE POLYMORPHISMS CORRELATE WITH LIVER FIBROSIS AND VIROLOGIC RESPONSE TO PEGYLATED INTERFERON PLUS RIBAVIRIN THERAPY IN PATIENTS WITH GENOTYPE 1 INFECTION [J].
Hsu, Ching-Sheng ;
Hsu, Shih-Jer ;
Liu, Chen-Hua ;
Liu, Chun-Jen ;
Chen, Pei-Jer ;
Kao, Jia-Horng .
HEPATOLOGY, 2010, 52 (04) :761A-761A
[48]   Cytokine response in chronic hepatitis C (CHC) patients treated with pegylated interferon plus ribavirin [J].
Trapero-Marugan, M. ;
Garcia-Buey, L. ;
Munoz, C. ;
Moreno-Monteagudo, J. A. ;
Borque, M. J. ;
Salcedo-Mora, X. ;
Moreno-Otero, R. .
JOURNAL OF HEPATOLOGY, 2006, 44 :S227-S228
[49]   Erythropoietic response to anemia in chronic hepatitis C patients receiving combination pegylated interferon/ribavirin [J].
Balan, V ;
Schwartz, D ;
Wu, GY ;
Muir, AJ ;
Ghalib, R ;
Jackson, J ;
Keeffe, EB ;
Rossaro, L ;
Burnett, A ;
Goon, BL ;
Bowers, PJ ;
Leitz, GJ .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (02) :299-307
[50]   Immunological biomarkers of virological response in patients with chronic hepatitis C treated with pegylated interferon and ribavirin [J].
Menezes, E. ;
Reis, J. ;
Cardoso, L. ;
Teixeira Carvalho, A. ;
Filho, A. M. O. ;
Teixeira, R. .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 :1269-1269
12345